Resource Center

Catch up on recent videos from the webinar with Viz.ai, The PERT Consortium and Endovascular Today.

Timely diagnosis in stroke management is of critical importance, and AI-tools can play a central role in timely diagnosis and treatment planning. The use of an AI tool can accelerate diagnosis and management by virtue of rapid automated interpretation and turnaround of emergency cases.

Learn about the PERT (Pulmonary Embolism Response Team) model and advantages of AI-powered care coordination.

Radiology experts join Viz.ai to talk about the latest trends - from rising study volume and radiologists shortages to artificial intelligence and workflow efficiency. Whether your practice is using AI today or not, join us to compare notes, hear lessons learned and real-world evidence of how AI is moving the needle.

"This algorithm leverages AI to automatically search for the presence of a suspected abdominal aortic aneurysm (AAA) from any computed tomography angiography (CTA) from any scanner in any institution in a hospital network that uses the company’s platform."

Join leading cardiac electrophysiology experts, Dr. Suneet Mittal, Valley Health and Dr. Jonathan Hsu, University of California, San Diego, as they discuss their real world experience with AI to seamlessly direct patients to the right specialist, combating loss to follow up rates and delayed diagnosis in cryptogenic stroke and hypertrophic cardiomyopathy.

Emergency surgery to put a stent in the 23-year-old's neck helped him return to life pretty much as normal.

Emergency surgery to put a stent in the 23-year-old's neck helped him return to life pretty much as normal.

Viz.ai is developing Viz HCM, AI-powered software to analyze ECGs and auto-detect signals associated with HCM.

A new multicenter study showed that up to 85% of aneurysms detected by AI had not been previously referred for follow-up to the appropriate specialist. Dr. Sunil Sheth, primary investigator, will highlight the study results.

Six technology companies provide 6-minute presentations on DCTs and better patient access. During the Viz.ai segment, hear from Principal Investigators on how they efficiently source and enroll patients identified in the medical practice setting using AI.

Viz.ai shares new clinical data on Viz Pulmonary Embolism (PE). Understand how Viz PE performs in diverse, real-world settings and bring your questions to our expert team in this 30-minute express webinar.

Emily S. Perrinez, RN, MSN, MPH, Director, Telehealth at UCSD discusses optimizing post-acute ischemic stroke workflow and collaboration to mitigate the complex care pathway challenges of cryptogenic

In under four minutes hear Dr. Ameer Hassan present stroke outcomes pre and post Viz.ai on from a large hospital network. The study measured DIDO time, door-In to puncture time and more.

In under four minutes hear Dr. Ameer Hassan present stroke outcomes pre and post Viz.ai on from a large hospital network. The study measured DIDO time, door-In to puncture time and more.

David will discuss how Viz.ai is increasing access to life-saving treatments, the journey from bringing their products into production, how the AI team is set up for success, case studies, and more.

Viz.ai shares real-world evidence on Viz AORTIC. See Viz AORTIC and Viz™ PE in action and bring your questions to our expert team in this 30-minute express webinar.

Dr. Sabeen Dhand interviews vascular surgeon Dr. Benjamin Starnes about AI in aortic intervention, from aneurysm detection to procedural planning and coordination of aortic aneurysm surveillance.

Jayme Strauss, Chief Clinical Officer at Viz.ai speaks at Mobile Tech in Clinical Trials 2022.

Jayme Strauss, Chief Clinical Officer at Viz.ai speaks at Mobile Tech in Clinical Trials 2022.

Viz.ai CEO Chris Mansi on Artificial Intelligence and Increasing Patient Access to Life-Saving Treatments

Case study of successful LVO procedure at UPMC Hamot

Viz LVO’s impact at primary stroke centers and comprehensive stroke centers

Viz.ai is now focused on positioning its joined-up AI software as standardsetter for broader patient engagement with big pharma.

Case study of Viz.ai implementation for a mid-size hub/spoke hospital system in the US Ohio Valley.

Commonly asked questions from clinical operations executives across top pharmaceutical and medical device companies regarding Viz RECRUIT capabilities.

Dr. Neil Haranhalli, Assistant Professor of Neurosurgery at Montefiore Medical Center in New York discusses Viz Aneurysm and SDH.

Dr. Neil Haranhalli, Assistant Professor of Neurosurgery at Montefiore Medical Center in New York discusses Viz Aneurysm and SDH.

Read about how Boca Raton Regional Hospital has been able to obtain NTAP reimbursement for over 150 qualifying cases while using Viz.ai.

Dr. Kevin Abrams shares how Viz.ai has positively impacted his radiology practice.

Dr. Kevin Abrams shares how Viz.ai has positively impacted his radiology practice.

Dr. Eric Eskioglu shares how Viz.ai has supported Novant Health to improve patient outcomes.

Dr. Eric Eskioglu shares how Viz.ai has supported Novant Health to improve patient outcomes.

Daniel D'Amour of Viz.ai speaking at ISC 2022

The right AI-powered care coordination solution can help you reduce time to care and improve care outcomes for patients with severe vascular disease like pulmonary embolism and aortic emergencies.

Multidisciplinary care team coordination is one of the biggest challenges facing specialists. Viz.ai offers a powerful alternative to traditional care coordination workflow.

In our fifth episode related to AI in MedTech, we Zoom travel to Israel to visit with David Golan, CTO and Co-Founder of Viz.ai to discuss how AI plays a role in their technology.

In this short ebook, we discuss how the Viz.ai platform addresses the following pain points to help these teams perform their jobs more efficiently and with less wasted effort.

Healthcare organizations that understand the coming trends will have a significant advantage in staying ahead of the curve and continuing to provide superior care at a lower organizational cost.

View this free infographic to see the numbers of how Viz.ai is changing patient lives and what was accomplished in 2021.

Find out how Viz was rolled out across Piedmont Healthcare's 11 hospital system.

Learn why Viz.ai is a clinically proven AI platform that provides a more clinically impactful solution for both the radiologist and the broader care team.

Viz.ai is the only artificial intelligence solution with modules for the detection of suspected pulmonary embolism and aortic disease.

The COVID-19 pandemic has changed hospital economics. Hospitals are forced to limit elective procedures and patients are foregoing care even for emergencies...

May is Stroke Awareness Month. Learn about how to recognize the signs of a stroke.

May is Stroke Awareness Month. Learn about how to recognize the signs of a stroke.

Discover what's new from Viz.ai.

Dr. Michelle Whaley Acute Neurovascular Clinical Nurse Specialist. Sky Ridge Medical Center discusses Significantly Reducing Door to Puncture Times with Viz.ai at Sky Ridge Medical Center.

Dr. Donald Frei goes over the Swedish Medical Center Experience.

Dr. Quill Turk goes over the Prisma Health Exprience.

Delivering unparalleled Intracranial Hemorrhage (ICH) detection, automated alerts, and workflow optimization. Powered by AI, Viz ICH detects suspected intracranial hemorrhage in...

Connecting Multidisciplinary Beyond Neurovascular, Improving Outcomes for Patients and Improving Hospital Economics.

Connect multi-disciplinary care teams earlier, coordinate care, and improve outcomes for patients.

Coordinate Care from the Ambulance to the Follow-Up Visit Connect EMS services to the stroke team, and connect patients to specialists for follow-up after treatment.

Jayme Strauss, RN, MSN, MBA, SCRN Executive Director of Neuroscience Piedmont Healthcare talks about Viz.ai and NTAP.

Jayme Strauss, RN, MSN, MBA, SCRN Executive Director of Neuroscience Piedmont Healthcare talks about Viz.ai and NTAP.

Jayme Strauss, RN, MSN, MBA, SCRN Executive Director of Neuroscience Piedmont Healthcare talks about Viz.ai and NTAP.

Neuroscience executive Jayme Strauss and Viz.ai CEO and Co-Founder Dr. Chris Mansi discuss Viz, its clinical benefit to patients, and the impact of the New Technology Add-On Payment (NTAP)...

A prospectively maintained database was assessed for all patients who presented to a PSC currently utilizing Viz LVO in the Mount Sinai Health System in New York...

We compared the time interval between door-in and door-out for all LVO transfer patients from a single spoke PSC to our CSC...

We compared the time interval between door-in to groin puncture for all LVO transfer patients who arrived at our comprehensive care center for approximately two years...

Endovascular treatments (EVT) such as intra-arterial thrombolysis or mechanical thrombectomy (MT) are widely proven methods to treat patients suffering a large vessel occlusion (LVO)....

Every year, patients suffer from almost 800,000 strokes in the US alone. When it comes to brain injury, the deciding factor on whether a patient lives or dies is time. In this resource...

May is Stroke Awareness Month. Please read this brief guide to learn about the different types of stroke, the warning signs and symptoms, and prevention.

In 2020, stroke is the leading cause of disability and the second leading cause of death worldwide. Knowing the signs of stroke can help you or a loved one access care faster and help save a life.

In 2020, stroke is the leading cause of disability and the second leading cause of death worldwide. Knowing the signs of stroke can help you or a loved one access care faster and help save a life.

Viz LVO (formally ContaCT) has demonstrated substantial clinical improvement to CMS and has officially been granted a New Technology Add-On Payment.

Use of Artificial Intelligence Shows Significant Reduction in Door to Skin Puncture Times at a Stroke Center.

Impact of Viz LVO on Time-to-Treatment and Clinical Outcomes in Large Vessel Occlusion Stroke Patients Presenting to Primary Stroke Centers.

Early Experience Utilizing Artificial Intelligence Shows Significant Reduction in Transfer Times & Length of Stay in a Hub & Spoke Model.

A multi-center review of time savings, improved outcomes, and increased access to care.

Immediately access and update relevant information about the patient as soon it is entered into the app or the EHR.

In CTAs from 2,544 consecutive patients across 139 US hospitals using scanners from multiple manufacturers, Viz LVO has demonstrated 96% sensitivity and 94% specificity identifying LVOs.

NTAP is an additional payment for hospital stays that use new technology determined by CMS to provide substantial clinical improvement and where the current MS-DRG payment would be inadequate.